Poziotinib for HER2 Exon 20-Mutated NSCLC: Addition or Burden to the Therapeutic Arsenal? Borm FJ, Smit EF. J Thorac Oncol 2023;18:964-966.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borm FJ, Smit EF. Poziotinib for HER2 Exon 20-Mutated NSCLC: Addition or Burden to the Therapeutic Arsenal? J Thorac Oncol 2023;18:964-966.
PMID: 37479324